| What it does | Systematic review and meta-analysis platform for literature screening, data extraction, and evidence synthesis
| SEC insider filings screener for Forms 3, 4 and 5
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2026
|
|---|
| Based in | IN
| DE
|
|---|
| Pricing model | Freemium
| Free
|
|---|
| Pricing | Free: Core platform with literature import, manual screening, extraction, meta-analysis, PRISMA 2020 flow diagrams, omics dashboard, report export, team collaboration, and 50 free AI actions. AI Assistant: ₹399/month, cancel anytime, includes AI-assisted screening, AI relevance scoring, AI extractio
| Not given
|
|---|
| Key features | - Full-text screening with inclusion/exclusion criteria
- Automated data extraction with AI auto-fill
- Forest plots and funnel plots
- Literature import from PubMed, Scopus, RIS, BibTeX, CSV
| - Search SEC Forms 3, 4 and 5 by ticker, reporting owner, filing date, trade date, transaction code, and insider role
- Predefined screens for large purchases, director purchases, officer purchases and large sales
- CSV export for filing data analysis
- API access to normalized transaction data
- Email notifications and alerts for insider filings
- RSS feeds for latest filings and specialist screens
- Filing footnotes preserved for transaction context
- Links to original SEC EDGAR filings for verification
- Filters for non-derivative transactions and specified transaction codes
|
|---|
| What makes it different | - Free core platform with no seat limits or time restrictions
- Single unified workflow from screening to publication without switching tools
- All data stays portable and exportable as CSV, JSON, and PDF
- AI-powered study prioritization based on research question and PICO framework
- Omics research integration alongside traditional systematic reviews
| - Structures SEC filing data with transaction codes, reporting-owner roles and ownership context rather than just listing raw filings
- Distinguishes actual purchases and sales from grants, option exercises and tax-related transactions
- Preserves filing-level details and source context for informed interpretation
- Provides estimated P/S prices and cash values as screening aids calculated from parsed data
|
| Community votes | 0 | 1 |
| DR (Domain Rating by Ahrefs) | Not checked yet ● no change since last check | 7 ● no change since last check |
| Trust Flow (Majestic) | 0 | 4 |
| Citation Flow (Majestic) | 22 | 16 |
| Referring domains (Majestic) | 11 | 15 |